23.66k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | -0.15% | - | - | - |
^GSPC | -0.16% | +0.03% | -14.26% | +4170.18% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 151.82 | -1.48 | -0.97% | 4:00 pm GMT-4 | 6.11M | 8.25M | 473.65B |
ABBV | AbbVie Inc. | 158.25 | +0.71 | +0.45% | 4:03 pm GMT-4 | 3.45M | 6.41M | 279.18B |
PFE | Pfizer Inc. | 39.99 | -0.23 | -0.57% | 4:03 pm GMT-4 | 13.34M | 23.20M | 225.72B |
SNY | Sanofi | 54.19 | +0.97 | +1.82% | 4:00 pm GMT-4 | 1.51M | 2.01M | 135.34B |
GILD | Gilead Sciences, Inc. | 80.97 | +1.39 | +1.75% | 4:00 pm GMT-4 | 3.48M | 6.25M | 101.12B |
REGN | Regeneron Pharmaceuticals, Inc. | 826.97 | +6.56 | +0.80% | 4:00 pm GMT-4 | 362.61k | 646.17k | 90.41B |
GSK | GSK plc | 35.1 | +0.06 | +0.17% | 4:00 pm GMT-4 | 3.01M | 3.70M | 71.87B |
MRNA | Moderna, Inc. | 146.92 | -1.43 | -0.96% | 4:00 pm GMT-4 | 1.99M | 3.63M | 56.66B |
TAK | Takeda Pharmaceutical Company Limited | 16.44 | -0.04 | -0.24% | 4:00 pm GMT-4 | 1.17M | 2.73M | 51.31B |
BNTX | BioNTech SE | 123 | -0.60 | -0.49% | 4:00 pm GMT-4 | 783.32k | 688.42k | 29.64B |
VIR | Vir Biotechnology, Inc. | 22.6 | -0.41 | -1.78% | 4:00 pm GMT-4 | 605.35k | 1.03M | 3.02B |
NVAX | Novavax, Inc. | 6.16 | +0.07 | +1.15% | 4:00 pm GMT-4 | 2.42M | 6.62M | 530.83M |
INO | Inovio Pharmaceuticals, Inc. | 0.8611 | -0.05 | -5.76% | 4:00 pm GMT-4 | 5.72M | 4.43M | 224.00M |
In this article, we will discuss the 10 cheap stocks to buy now according to Jim Cramer. If you want to explore similar stocks, you can also take a look at 5 Cheap Jim Cramer Stocks to Buy Now. “The Initial Move Is Almost Always A Head Fake” On March 22, the Fed raised interest […]
Gilead Sciences (GILD) closed at $80.99 in the latest trading session, marking a +1.77% move from the prior day.
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.